Paris, France

Marie-Christine Bouton

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Universite Paris Xiii Paris-Nord, Inserm (Institut National De La Santé Et De La Recherche Médicale), National Institute of Health and Medical Research. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marie-Christine Bouton. Retrieved from https://idiyas.com/inventor/marie-christine-bouton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marie-Christine Bouton: Innovator in Hemophilia Treatment

Introduction

Marie-Christine Bouton is a notable inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of hemorrhagic diseases. Her innovative approach has led to the development of a unique method for treating hemophilia A.

Latest Patents

Marie-Christine Bouton holds a patent for "Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A." This invention relates to methods and compositions aimed at addressing hemorrhagic diseases, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Bouton has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université Paris Diderot - Paris 7. Her work in these organizations has allowed her to focus on groundbreaking research and innovation in the medical field.

Collaborations

Marie-Christine has collaborated with notable professionals in her field, including Petrus Lenting and Cécile Denis. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Marie-Christine Bouton's contributions to the treatment of hemophilia A exemplify her dedication to medical innovation. Her work continues to inspire advancements in healthcare and improve the lives of those affected by hemorrhagic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…